Age-matched male CBA mice on a conventional or a vitamin A acetate (VAOAc)-rich diet were immunized with irradiated cloned 3-methylcholanthrene-or Harvey sarcoma virus-induced (McSa-I or HT3,2.1) sarcoma cells and then challenged with viable corresponding or unrelated (non-crossreacting) syngeneic sarcoma cells. The survival, of the specifically immunized mice on the VAOAc diet was significantly prolonged in comparison with all control groups of mice as assessed by using logrank tests. Moreover, the specific immunization markedly decreased the incidence of tumors after the McSa-1 (but not HT3-2.1) challenge in a group of mice on the VAOAc diet (5% tumor incidence) compared with-the equivalent group on the control diet (50% tumor incidence). Neither the VAOAc diet nor in vivo immunization alone or combined influenced. natural-killer cell. activity. Specific T-cell-mediated cytotoxicity after in vivo priming and in vitro boosting with sarcoma cells was increased in VAOAcfed mice. However, the marginal increase in cytotoxicity does not in itself explain the strikingly increased resistance to tumor transplants in preimmunized mice on the VAOAc diet in comparison with preimmunized mice on the control diet. The results indicate that a diet enriched in VAOAc can modify the ability of the immune system of a mouse to respond effectively to tumor antigens and can influence whether a tumor grows or regresses.A connection between the risk of cancer and a substance discovered in the beginning of this century (1-4) and subsequently named vitamin A (5) was revealed in 1926 when susceptibility to carcinomas of the stomach in rats fed a vitamin Adeficient diet was observed (6). Since that time, a vast literature suggesting that vitamin A and retinoids (naturally occurring and synthetic derivatives of vitamin A) generally retard or prevent malignant transformation, suppress tumor promotion, or even cause reversion of transformed cells and regression of certain tumors has accumulated (reviewed in refs. 7 and 8). The mechanisms of these manifold anticancer effects are still conjectural (7,8). However, re-tinoid substances can also act as potent immunoregulatory agents (9-18). It has been proposed, but not supported experimentally, that, besides any direct anticancer activity retinoids might exercise, their antitumor effect might be an outcome of the enhancement of host antitumor immune responses (18)(19)(20)(21).This view has been upheld by in vitro studies by Dennert et al. (22) who have shown an augmented antitumor cytotoxic activity of splenic T lymphocytes in mice injected with retinoic acid. Moreover, using the tumor-cell neutralization (Winn)